Ready-made stem cell therapies for pets could be coming

July 5, 2025

, By Techcrunch

Share via:

Earlier this week, San Diego startup Gallant announced rel=”nofollow” href=”https://www.gallant.com/news/gallant-closes-18-million-series-b-to-bring-ready-to-use-stem-cell-therapies-for-pets-to-market/”>$18 million in funding to bring the first FDA-approved ready-to-use stem cell therapy to veterinary medicine. If it passes regulatory muster, it could create a whole new way to treat our fur babies.

It’s still an experimental field, even though people have been researching stem cells for humans for decades. Seven-year-old Gallant’s first target is a painful mouth condition in cats called Feline Chronic Gingivostomatitis (FCGS), which Gallant says could receive FDA approval by early…

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Previous News

Nano Labs Invests $50M in BNB, Eyes $1 Billion in Treasury

Next News

MacBook, iPad Pro, MagSafe Charger, Find My gear, more 9to5Mac

Popular

More Like this

Ready-made stem cell therapies for pets could be coming

July 5, 2025

, Published By Techcrunch

Earlier this week, San Diego startup Gallant announced rel=”nofollow” href=”https://www.gallant.com/news/gallant-closes-18-million-series-b-to-bring-ready-to-use-stem-cell-therapies-for-pets-to-market/”>$18 million in funding to bring the first FDA-approved ready-to-use stem cell therapy to veterinary medicine. If it passes regulatory muster, it could create a whole new way to treat our fur babies.

It’s still an experimental field, even though people have been researching stem cells for humans for decades. Seven-year-old Gallant’s first target is a painful mouth condition in cats called Feline Chronic Gingivostomatitis (FCGS), which Gallant says could receive FDA approval by early…

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

Previous News

Nano Labs Invests $50M in BNB, Eyes $1 Billion in Treasury

Next News

MacBook, iPad Pro, MagSafe Charger, Find My gear, more 9to5Mac

More like this

Popular

Block title